info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Mice Model Market Research Report Information By Model Type & Service (Model Type, (Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Outbred Mice), Service, (Breeding, Cryopreservation, Rederivation, Quarantine and Other Services)), By Technology (CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies), By Therapeutic Area (Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases and Other Therapeutic Diseases), By Application (Drug Discovery & Development, Rese


ID: MRFR/HC/20372-HCR | 128 Pages | Author: Rahul Gotadki| July 2024

Mice Model Market


Mice Model Model Type & Service Outlook (USD Billion, 2019-2032)




  • Model Type




    • Inbred Mice




    • Genetically Engineered Mice




    • Hybrid/Congenic Mice




    • Outbred Mice






  • Service




    • Breeding




    • Cryopreservation




    • Rederivation




    • Quarantine




    • Other services






Mice Model Technology Outlook (USD Billion, 2019-2032)




  • CRISPR/CAS9




  • Microinjection




  • Embryonic Stem Cell Injection




  • Nuclear Transfer




  • Other Technologies




Mice Model Therapeutic Area Outlook (USD Billion, 2019-2032)




  • Oncology




  • Metabolic Diseases




  • Immunology




  • Neurology




  • Cardiovascular Diseases




  • Other Therapeutic Diseases




Mice Model Application Outlook (USD Billion, 2019-2032)




  • Drug Discovery & Development




  • Research Application




  • Personalized Medicine




Mice Model End User Outlook (USD Billion, 2019-2032)




  • Pharmaceutical & Biotechnology Companies




  • Academic & Research Institutes




  • CROS & CDMOS




Mice Model Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




    • North America Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • North America Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • North America Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • North America Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • North America Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • US Outlook (USD Billion, 2019-2032)




    • US Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • US Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • US Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • US Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • US Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • CANADA Outlook (USD Billion, 2019-2032)




    • CANADA Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • CANADA Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • CANADA Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • CANADA Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • CANADA Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS








  • Europe Outlook (USD Billion, 2019-2032)




    • Europe Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Europe Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Europe Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Europe Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Europe Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Germany Outlook (USD Billion, 2019-2032)




    • Germany Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Germany Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Germany Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Germany Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Germany Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • France Outlook (USD Billion, 2019-2032)




    • France Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • France Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • France Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • France Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • France Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • UK Outlook (USD Billion, 2019-2032)




    • UK Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • UK Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • UK Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • UK Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • UK Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • ITALY Outlook (USD Billion, 2019-2032)




    • ITALY Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • ITALY Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • ITALY Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • ITALY Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • ITALY Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • SPAIN Outlook (USD Billion, 2019-2032)




    • Spain Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Spain Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Spain Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Spain Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Spain Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Rest Of Europe Outlook (USD Billion, 2019-2032)




    • Rest Of Europe Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • REST OF EUROPE Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • REST OF EUROPE Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • REST OF EUROPE Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • REST OF EUROPE Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS








  • Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Asia-Pacific Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Asia-Pacific Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Asia-Pacific Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Asia-Pacific Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Asia-Pacific Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • China Outlook (USD Billion, 2019-2032)




    • China Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • China Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • China Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • China Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • China Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Japan Outlook (USD Billion, 2019-2032)




    • Japan Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Japan Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Japan Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Japan Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Japan Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • India Outlook (USD Billion, 2019-2032)




    • India Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • India Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • India Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • India Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • India Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Australia Outlook (USD Billion, 2019-2032)




    • Australia Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Australia Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Australia Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Australia Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Australia Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Rest of Asia-Pacific Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Rest of Asia-Pacific Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Rest of Asia-Pacific Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Rest of Asia-Pacific Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Rest of Asia-Pacific Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS








  • Rest of the World Outlook (USD Billion, 2019-2032)




    • Rest of the World Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Rest of the World Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Rest of the World Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Rest of the World Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Rest of the World Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Middle East Outlook (USD Billion, 2019-2032)




    • Middle East Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Middle East Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Middle East Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Middle East Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Middle East Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Africa Outlook (USD Billion, 2019-2032)




    • Africa Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Africa Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Africa Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Africa Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Africa Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS






    • Latin America Outlook (USD Billion, 2019-2032)




    • Latin America Mice Model by Model Type & Service




      • Model Type




        • Inbred Mice




        • Genetically Engineered Mice




        • Hybrid/Congenic Mice




        • Outbred Mice






      • Service




        • Breeding




        • Cryopreservation




        • Rederivation




        • Quarantine




        • Other services








    • Latin America Mice Model by Technology




      • CRISPR/CAS9




      • Microinjection




      • Embryonic Stem Cell Injection




      • Nuclear Transfer




      • Other Technologies






    • Latin America Mice Model by Therapeutic Area




      • Oncology




      • Metabolic Diseases




      • Immunology




      • Neurology




      • Cardiovascular Diseases




      • Other Therapeutic Diseases






    • Latin America Mice Model by Application




      • Drug Discovery & Development




      • Research Application




      • Personalized Medicine






    • Latin America Mice Model by End User




      • Pharmaceutical & Biotechnology Companies




      • Academic & Research Institutes




      • CROS & CDMOS







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porterโ€™s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL MICE MODEL MARKET, BY MODEL TYPE & SERVICE

6.1. Overview

6.2. Model Type

6.2.1. Inbred Mice

6.2.2. Genetically Engineered Mice

6.2.3. Hybrid/Congenic Mice

6.2.4. Outbred Mice

6.3. Service

6.3.1. Breeding

6.3.2. Cryopreservation

6.3.3. Rederivation

6.3.4. Quarantine

6.3.5. Other services

7. GLOBAL MICE MODEL MARKET, BY TECHNOLOGY

7.1. Overview

7.2. CRISPR/CAS9

7.3. Microinjection

7.4. Embryonic Stem Cell Injection

7.5. Nuclear Transfer

7.6. Other Technologies

8. GLOBAL MICE MODEL MARKET, BY THERAPEUTIC AREA

8.1. Overview

8.2. Oncology

8.3. Metabolic Diseases

8.4. Immunology

8.5. Neurology

8.6. Cardiovascular Diseases

8.7. Other Therapeutic Diseases

9. GLOBAL MICE MODEL MARKET, BY APPLICATION

9.1. Overview

9.2. Drug Discovery & Development

9.3. Research Application

9.4. Personalized Medicine

10. GLOBAL MICE MODEL MARKET, BY END USER

10.1. Overview

10.2. Pharmaceutical & Biotechnology Companies

10.3. Academic & Research Institutes

10.4. CROS & CDMOS

11. GLOBAL MICE MODEL MARKET, BY REGION

11.1. Overview

11.1. North America

11.1.1. US

11.1.2. Canada

11.2. Europe

11.2.1. Germany

11.2.2. France

11.2.3. UK

11.2.4. Italy

11.2.5. Spain

11.2.6. Rest of Europe

11.3. Asia-Pacific

11.3.1. China

11.3.2. India

11.3.3. Japan

11.3.4. South Korea

11.3.5. Australia

11.3.6. Rest of Asia-Pacific

11.4. Rest of the World

11.4.1. Middle East

11.4.2. Africa

11.4.3. Latin America

12. COMPETITIVE LANDSCAPE

12.1. Overview

12.2. Competitive Analysis

12.3. Market Share Analysis

12.4. Major Growth Strategy in the Global Mice Model Market,

12.5. Competitive Benchmarking

12.6. Leading Players in Terms of Number of Developments in the Global Mice Model Market,

12.7. Key developments and Growth Strategies

12.7.1. New Product Launch/Service Deployment

12.7.2. Merger & Acquisitions

12.7.3. Joint Ventures

12.8. Major Players Financial Matrix

12.8.1. Sales & Operating Income, 2023

12.8.2. Major Players R&D Expenditure. 2023

13. COMPANY PROFILES

13.1. Charles River Laboratories International, Inc.

13.1.1. Company Overview

13.1.2. Financial Overview

13.1.3. Products Offered

13.1.4. Key Developments

13.1.5. SWOT Analysis

13.1.6. Key Strategies

13.2. Taconic Biosciences, Inc.

13.2.1. Company Overview

13.2.2. Financial Overview

13.2.3. Products Offered

13.2.4. Key Developments

13.2.5. SWOT Analysis

13.2.6. Key Strategies

13.3. The Jackson Laboratory

13.3.1. Company Overview

13.3.2. Financial Overview

13.3.3. Products Offered

13.3.4. Key Developments

13.3.5. SWOT Analysis

13.3.6. Key Strategies

13.4. Envigo

13.4.1. Company Overview

13.4.2. Financial Overview

13.4.3. Products Offered

13.4.4. Key Developments

13.4.5. SWOT Analysis

13.4.6. Key Strategies

13.5. JANVIER Labs

13.5.1. Company Overview

13.5.2. Financial Overview

13.5.3. Products Offered

13.5.4. Key Developments

13.5.5. SWOT Analysis

13.5.6. Key Strategies

13.6. GenOway S.A.

13.6.1. Company Overview

13.6.2. Financial Overview

13.6.3. Products Offered

13.6.4. Key Developments

13.6.5. SWOT Analysis

13.6.6. Key Strategies

13.7. Horizon Discovery Group plc

13.7.1. Company Overview

13.7.2. Financial Overview

13.7.3. Products Offered

13.7.4. Key Developments

13.7.5. SWOT Analysis

13.7.6. Key Strategies

13.8. HARBOUR BIOMED

13.8.1. Company Overview

13.8.2. Financial Overview

13.8.3. Products Offered

13.8.4. Key Developments

13.8.5. SWOT Analysis

13.8.6. Key Strategies

13.9. Crown Bioscience Inc.

13.9.1. Company Overview

13.9.2. Financial Overview

13.9.3. Products Offered

13.9.4. Key Developments

13.9.5. SWOT Analysis

13.9.6. Key Strategies

13.10. INVIVOS PTE LTD.

13.10.1. Company Overview

13.10.2. Financial Overview

13.10.3. Products Offered

13.10.4. Key Developments

13.10.5. SWOT Analysis

13.10.6. Key Strategies

14. APPENDIX

14.1. References

14.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL MICE MODEL MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL MICE MODEL MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 6 GLOBAL MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 7 GLOBAL MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 9 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 10 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 11 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 13 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 14 US: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 15 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 16 US: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 17 US: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 18 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 19 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 20 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 21 CANADA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 22 CANADA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 23 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 24 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 25 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 26 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 EUROPE: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 28 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 29 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 30 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 31 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 32 GERMANY: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 33 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 34 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 35 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 36 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 37 FRANCE: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 38 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 39 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 40 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 41 ITALY: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 ITALY: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 43 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 44 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 45 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 46 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 47 SPAIN: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 48 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 49 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 50 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 51 UK: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 52 UK: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 53 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 54 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 55 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 56 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 57 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 58 ASIA-PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 59 ASIA-PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 60 ASIA-PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 61 ASIA-PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 62 ASIA-PACIFIC: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 63 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 64 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 65 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 66 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 67 JAPAN: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 68 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 69 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 70 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 71 CHINA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 72 CHINA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 73 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 74 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 75 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 76 INDIA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 77 INDIA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 78 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 79 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 80 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 81 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 82 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 83 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 84 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 85 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 86 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 87 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 88 REST OF ASIA-PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 89 REST OF ASIA-PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 90 REST OF ASIA-PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 91 REST OF ASIA-PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 92 REST OF ASIA-PACIFIC: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 93 REST OF THE WORLD: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 94 REST OF THE WORLD: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 95 REST OF THE WORLD: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 96 REST OF THE WORLD: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 97 REST OF THE WORLD: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 98 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 99 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 100 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 101 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 102 MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 103 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 104 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 105 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 106 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 107 AFRICA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

TABLE 108 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2019-2032 (USD BILLION)

TABLE 109 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 110 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)

TABLE 111 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 112 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MICE MODEL MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MICE MODEL MARKET

FIGURE 4 GLOBAL MICE MODEL MARKET, SHARE (%), BY MODEL TYPE & SERVICE, 2023

FIGURE 5 GLOBAL MICE MODEL MARKET, SHARE (%), BY TECHNOLOGY, 2023

FIGURE 6 GLOBAL MICE MODEL MARKET, SHARE (%), BY THERAPEUTIC AREA, 2023

FIGURE 7 GLOBAL MICE MODEL MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 8 GLOBAL MICE MODEL MARKET, SHARE (%), BY END USER, 2023

FIGURE 9 GLOBAL MICE MODEL MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 NORTH AMERICA: MICE MODEL MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 EUROPE: MICE MODEL MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 ASIA-PACIFIC: MICE MODEL MARKET, SHARE (%), BY REGION, 2023

FIGURE 13 REST OF THE WORLD: MICE MODEL MARKET, SHARE (%), BY REGION, 2023

FIGURE 14 GLOBAL MICE MODEL MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 15 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SWOT ANALYSIS

FIGURE 17 TACONIC BIOSCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 TACONIC BIOSCIENCES, INC.: SWOT ANALYSIS

FIGURE 19 THE JACKSON LABORATORY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 THE JACKSON LABORATORY: SWOT ANALYSIS

FIGURE 21 ENVIGO: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 ENVIGO: SWOT ANALYSIS

FIGURE 23 JANVIER LABS.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 JANVIER LABS.: SWOT ANALYSIS

FIGURE 25 GENOWAY S.A.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 GENOWAY S.A.: SWOT ANALYSIS

FIGURE 27 HORIZON DISCOVERY GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 HORIZON DISCOVERY GROUP PLC: SWOT ANALYSIS

FIGURE 29 HARBOUR BIOMED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 HARBOUR BIOMED: SWOT ANALYSIS

FIGURE 31 CROWN BIOSCIENCE INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 CROWN BIOSCIENCE INC.: SWOT ANALYSIS

FIGURE 33 INVIVOS PTE LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 INVIVOS PTE LTD.: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.